Highlights
A collection of news and information related to Regeneron Pharmaceuticals Incorporated published by this site and its partners.
Displaying items 1-12 of 12
» View wsbtradio.com items only
-
U.S. RESEARCH ROUNDUP: Microsoft, ICE, Actavis, Boeing
ReutersMay 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Actavis, and Microsoft, on Tuesday. HIGHLIGHTS * Microsoft Corp : Janney, UBS raise price target on stock * Boeing : UBS...Tags: Goldman Sachs Group, Inc., FedEx Corporation, FMC Technologies Incorporated, GameStop Corp., Lifestyle and Leisure
-
Regeneron, Sanofi asthma drug seen as potential game changer
Reuters(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said...Tags: Inflammation, Symptoms, Respiratory Disease, Trials, Science and Technology
-
U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney
ReutersMay 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...Tags: Personal Data Collection, Tesla Motors, Inc., Verizon Communications, DirecTV Group Inc., Autodesk Incorporated
-
U.S. RESEARCH ROUNDUP: Apple, Berkshire Hathaway, Walt Disney, AIG
ReutersMay 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, Berkshire Hathaway and Walt Disney, on Monday. HIGHLIGHTS * Apple : Barclays ups target price to $525 from $465; rating...Tags: Harley-Davidson Inc., Ameren Corporation, Tesla Motors, Inc., Telephone and Data Systems Inc., Lincoln National Corporation
-
Regeneron raises 2013 Eylea sales view, profit beats Street
ReutersMay 3 (Reuters) - Regeneron Pharmaceuticals Inc's first-quarter results beat analysts' estimates for the seventh straight quarter as the sales of its eye drug Eylea continued to gather pace, and the company raised its 2013 sales estimate for the drug....Tags: Thomson Corporation, Economy, Business and Finance, Earnings Forecasts, Roche Holding AG, Macular Degeneration
-
U.S. RESEARCH ROUNDUP: Berkshire, Fortinet, Aetna, NextEra Energy
ReutersMay 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...Tags: Goldman Sachs Group, Inc., Fidelity National Information Services Incorporated, Tesla Motors, Inc., Old National Bancorp, Rowan Companies Incorporated
-
BRIEF-Regeneron Pharma shares halted, last up 14.3 pct
ReutersNEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares halted, last up 14.3 percent -
BRIEF-Regeneron Pharma shares resume trading, up 16 percent
ReutersNEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval likely delayed * Shares up 13.2 percent as shares of Allergan slide after co...Tags: Allergan Inc.
-
U.S. RESEARCH ROUNDUP: Time Warner, Walt Disney, Riverbed Technology
ReutersApril 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Walt Disney and Microsoft, on Tuesday. HIGHLIGHTS * Walt Disney : Evercore raises price target to $68 from $58; rating...Tags: Lear Corporation, Old National Bancorp, Five Star Quality Care Incorporated, Roper Industries Inc., Tyco International Limited
-
BRIEF-S&P 500 to add Regeneron, drop MetroPCS
ReutersApril 24 (Reuters) - * S&P says to add Regeneron Pharmaceuticals Inc to S&P 500 * S&P says Regeneron to replace MetroPCS Communications Inc which is expected to merge with t-Mobile USA inc * S&P says change to be made after close of trading on April 30Tags: Stock Market, S&P 500
-
BRIEF-Regeneron Pharma shares up 2.8 pct after the bell
ReutersNEW YORK, April 24 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares up 2.8 percent after the bell, to join S&P 500 next weekTags: S&P 500
-
|Story
May 21, 2013
|Story| Reuters
May 21, 2013
|Story| Reuters
May 17, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 1, 2013
|Story| Reuters
May 1, 2013
|Story| Reuters
May 1, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Apr 24, 2013
|Story| Reuters
Apr 24, 2013
|Story| Reuters
Jun 17, 2011
|Story| AP Broadcast
Original site for Regeneron Pharmaceuticals Incorporated topic gallery.